Actively Recruiting
A Study to Predict Long-Term Outcomes and Survival in Erdheim-Chester Disease Using a New Prognostic Score
Led by Meyer Children's Hospital IRCCS · Updated on 2026-03-06
1000
Participants Needed
7
Research Sites
26 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying Erdheim-Chester disease ECD, a rare condition that causes abnormal accumulation of certain immune cells in various body parts such as bones, heart, brain, and kidneys. ECD affects adults mostly but can also occur in children aged 7 and older. The disease varies widely, from mild to severe forms with multiple organs involved. It is linked to specific genetic mutations affecting cell signaling pathways, which lead to inflammation and tissue damage. This study aims to improve understanding of long-term outcomes, survival, disability, and quality of life for patients with ECD, addressing gaps in current knowledge and prognosis prediction. Patients with ECD will be enrolled from multiple centers over five years, including both those currently receiving care and newly diagnosed individuals. Participants will have regular outpatient visits where clinical data related to organ involvement, treatment responses, and epidemiological factors will be collected. They will also complete questionnaires evaluating quality of life and other health outcomes. The study will observe patients without introducing new treatments, focusing on tracking disease progression and treatment effects over time. Throughout the study, participants will undergo comprehensive assessments including clinical evaluations and completion of detailed questionnaires about their health and daily functioning. Researchers will monitor survival rates over five years and analyze how organ damage, treatment response, side effects, comorbidities, and geographic factors relate to outcomes. The study emphasizes patient-reported outcomes such as chronic disability, depression, and cognitive function to better understand the diseases impact on quality of life. Follow-up will continue for at least one year for each participant to gather long-term data.
CONDITIONS
Brief Title
ECD-Score: a Study on Erdheim-Chester Disease
Research Team
A
Augusto Vaglio, Medical Doctor
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here